CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 103 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2019. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $727,000 | +19.0% | 104,543 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $611,000 | -56.6% | 104,543 | -43.9% | 0.00% | 0.0% |
Q3 2018 | $1,408,000 | +196.4% | 186,358 | +98.0% | 0.00% | 0.0% |
Q2 2018 | $475,000 | -17.2% | 94,117 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $574,000 | -4.2% | 94,117 | +11.6% | 0.00% | 0.0% |
Q4 2017 | $599,000 | -0.7% | 84,326 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $603,000 | +19.9% | 84,326 | +5.7% | 0.00% | 0.0% |
Q2 2017 | $503,000 | – | 79,780 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $6,307,000 | 4.30% |
ETF MANAGERS GROUP, LLC | 8,103,641 | $10,130,000 | 0.22% |
AdvisorShares Investments LLC | 271,873 | $340,000 | 0.08% |
Platform Technology Partners | 60,000 | $75,000 | 0.04% |
PINNACLE ASSOCIATES LTD | 942,079 | $1,178,000 | 0.02% |
HRT FINANCIAL LP | 883,510 | $1,104,000 | 0.02% |
Virtu Financial LLC | 153,908 | $192,000 | 0.02% |
Tekla Capital Management LLC | 413,481 | $517,000 | 0.02% |
Aries Wealth Management | 23,400 | $33,000 | 0.02% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 56,932 | $71,000 | 0.02% |